Composition for eliciting infectious immunological tolerance
AssigneeJunten Bio Co., Ltd.
InventorsKoichiro Uchida, Kazuyoshi Takeda, Ko Okumura
Life of this patent
Estimating the term…
Loading patent…
AssigneeJunten Bio Co., Ltd.
InventorsKoichiro Uchida, Kazuyoshi Takeda, Ko Okumura
Estimating the term…
The present disclosure provides a novel technique relating to immunological tolerance. More specifically, the present inventor found for the first time that, in a technique for inducing immunological tolerance by administering to an organ transplantation patient (a recipient) a cell preparation containing cells in which anergy is induced by an inhibitor inhibiting the interaction between CD80/CD86 and CD28, the immunological tolerance continues even after the disappearance of the cells derived from the cell preparation from the recipient (infectious immunological tolerance). Further, the present inventor proved that such a cell preparation can elicit immunological tolerance against immunological rejection caused by allergy, iPS cells, etc. or cells, tissues or organs derived therefrom.
-44. (canceled)
A method of eliciting permanent immune tolerance (infectious immune tolerance) to a donor in a subject, the method comprising administering to the subject an effective amount of a cell in which immune tolerance has been induced by a step that comprises mixing (i) an inhibitory factor that can inhibit an interaction between CD80 and/or CD86 and CD28, (ii) a cell derived from the subject, and (iii) an antigen derived from the donor or a composition comprising an antigen from the donor.
A method of treating or preventing a disease, disorder, or condition in a subject wherein the disease, disorder, or condition is caused by an antigen that is not derived from the subject, the method comprising administering to the subject an effective amount of a cell in which immune tolerance has been induced by a step that comprises mixing (i) an inhibitory factor that can inhibit an interaction between CD80 and/or CD86 and CD28, (ii) a cell derived from the subject, and (iii) one of (a) an antigen that is derived from the subject, (b) an antigen that is not derived from the subject, or (c) a composition comprising the antigen of (a) or (b).
Dependencies are inferred from the claim text.